Flemiphilippinin A
|
F646545-5mg
|
≥98% |
140366-64-9 |
5mg
|
¥ 7200.9
|
期货,请咨询 |
阿拉丁 |
Flemiphilippinin A
|
F646545-1mg
|
≥98% |
140366-64-9 |
1mg
|
¥ 2742.9
|
期货,请咨询 |
阿拉丁 |
FLT3-IN-6
|
F646497-5mg
|
≥99% |
2377141-31-4 |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
FLT3-IN-6
|
F646497-50mg
|
≥99% |
2377141-31-4 |
50mg
|
¥ 17000.9
|
期货,请咨询 |
阿拉丁 |
FLT3-IN-6
|
F646497-25mg
|
≥99% |
2377141-31-4 |
25mg
|
¥ 11000.9
|
期货,请咨询 |
阿拉丁 |
FLT3-IN-6
|
F646497-10mg
|
≥99% |
2377141-31-4 |
10mg
|
¥ 5800.9
|
期货,请咨询 |
阿拉丁 |
FLT3-IN-6
|
F646497-100mg
|
≥99% |
2377141-31-4 |
100mg
|
¥ 25000.9
|
期货,请咨询 |
阿拉丁 |
Filgotinib-d4
|
F646494-1mg
|
|
2041095-50-3 |
1mg
|
¥ 8900.9
|
期货,请咨询 |
阿拉丁 |
FW1256
|
F646416-5mg
|
≥98% |
117089-08-4 |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
FW1256
|
F646416-50mg
|
≥98% |
117089-08-4 |
50mg
|
¥ 22500.9
|
期货,请咨询 |
阿拉丁 |
FW1256
|
F646416-10mg
|
≥98% |
117089-08-4 |
10mg
|
¥ 6500.9
|
期货,请咨询 |
阿拉丁 |
FSHR agonist 1
|
F646397-5mg
|
≥98% |
1256776-89-2 |
5mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
FSHR agonist 1
|
F646397-1mg
|
≥98% |
1256776-89-2 |
1mg
|
¥ 2800.9
|
期货,请咨询 |
阿拉丁 |
FSHR agonist 1
|
F646397-10mg
|
≥98% |
1256776-89-2 |
10mg
|
¥ 13500.9
|
期货,请咨询 |
阿拉丁 |
FAP-2286
|
F646366-1mg
|
≥99% |
2581741-18-4 |
1mg
|
¥ 7200.9
|
期货,请咨询 |
阿拉丁 |
Fosifloxuridine nafalbenamide
|
F646347-5mg
|
|
1332837-31-6 |
5mg
|
¥ 2550.9
|
期货,请咨询 |
阿拉丁 |
Fosifloxuridine nafalbenamide
|
F646347-50mg
|
|
1332837-31-6 |
50mg
|
¥ 11200.9
|
期货,请咨询 |
阿拉丁 |
Fosifloxuridine nafalbenamide
|
F646347-25mg
|
|
1332837-31-6 |
25mg
|
¥ 7400.9
|
期货,请咨询 |
阿拉丁 |
Fosifloxuridine nafalbenamide
|
F646347-1mg
|
|
1332837-31-6 |
1mg
|
¥ 1790.9
|
期货,请咨询 |
阿拉丁 |
Fosifloxuridine nafalbenamide
|
F646347-10mg
|
|
1332837-31-6 |
10mg
|
¥ 3700.9
|
期货,请咨询 |
阿拉丁 |
Furaprofen
|
F646308-5mg
|
≥99% |
67700-30-5 |
5mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
Furaprofen
|
F646308-10mg
|
≥99% |
67700-30-5 |
10mg
|
¥ 13600.9
|
期货,请咨询 |
阿拉丁 |
Fluxametamide
|
F646301-5mg
|
≥98% |
928783-29-3 |
5mg
|
¥ 1200.9
|
期货,请咨询 |
阿拉丁 |
Fluxametamide
|
F646301-50mg
|
≥98% |
928783-29-3 |
50mg
|
¥ 6500.9
|
期货,请咨询 |
阿拉丁 |